Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia
Clinical trial NCT00117845 · TERMINATED
Trial details
- NCT number
- NCT00117845
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-11
- Primary completion
- 2011-12-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.